C4 Therapeutics OverviewC4 Therapeutics Other Income Expense Net
Other Income/Expense Net for CCCC.
Quarterly Other Income/Expense
$2.66M
↓ 6.54% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$10.16M
↓ 24.23% YoY
Trailing 12 months ending Mar 31, 2026